Stifel Financial Corp Pacira Bio Sciences, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $3,034 - $3,990	-84 Reduced 0.54%	15,513 $621,000
Q1 2023 May 12, 2023	SELL	$35.53 - $43.38 $5,080 - $6,203	-143 Reduced 0.91%	15,597 $636,000
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $6,530 - $9,823	-171 Reduced 1.07%	15,740 $607,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $54,878 - $63,071	1,071 Added 7.22%	15,911 $847,000
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $21,934 - $34,778	426 Added 2.96%	14,840 $866,000
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $726,002 - $925,070	-12,094 Reduced 45.62%	14,414 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $111,146 - $144,140	-2,317 Reduced 8.04%	26,508 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $157,854 - $177,095	2,889 Added 11.14%	28,825 $1.61 Million
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $756,616 - $894,822	12,785 Added 97.22%	25,936 $1.57 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $11,209 - $14,896	-189 Reduced 1.42%	13,151 $922,000
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $3,431 - $4,505	-68 Reduced 0.51%	13,340 $798,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $410,407 - $497,511	-7,897 Reduced 37.07%	13,408 $806,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $404,835 - $689,665	13,144 Added 161.06%	21,305 $1.12 Million
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $172,927 - $308,712	-6,089 Reduced 42.73%	8,161 $273,000
Q4 2019 Feb 13, 2020	SELL	$36.31 - $46.83 $31,734 - $40,929	-874 Reduced 5.78%	14,250 $642,000
Q3 2019 Nov 19, 2019	BUY	$35.66 - $44.99 $14,192 - $17,906	398 Added 2.7%	15,124 $580,000
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $13,158 - $16,601	369 Added 2.57%	14,726 $564,000
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $72,189 - $94,692	-1,974 Reduced 12.09%	14,357 $629,000
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $105,908 - $122,461	2,904 Added 21.63%	16,331 $625,000
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $35,774 - $45,170	-866 Reduced 6.06%	13,427 $578,000
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $184,222 - $291,616	5,608 Added 64.57%	14,293 $703,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $28,572 - $41,352	-1,039 Reduced 10.68%	8,685 $280,000
Q1 2018 May 11, 2018	SELL	$29.98 - $46.35 $33,517 - $51,819	-1,118 Reduced 10.31%	9,724 $304,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $46,978 - $69,251	1,475 Added 15.75%	10,842 $494,000
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $334,401 - $369,996	9,367	9,367 $0

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account